GENZYME CORP: ‘775 Patent Dispute with Impax Remains Ongoing

Genzyme Corporation remains in dispute with Impax Laboratories, Inc. over U.S. Patent No. 5,667,775, which expires in 2014.

The Company received notice in 2009, from Impax that it had submitted to…

SHIRE LTD: Sandoz Appeal on Patent Re-litigation Pending in CAFC

Sandoz Inc.’s appeal relating to the patent infringement case, Shire v Impax, remains pending, according to Shire Ltd.’s latest Quarterly Report filed with the U.S. Securities and Exchange Commission.

The U.S.…

GENZYME CORP: Pursues Patent Infringement Suits v. Lupin, Impax

Genzyme Corporation is pursuing lawsuits against Lupin Ltd. and Lupin Pharmaceuticals and Impax Laboratories, Inc., alleging infringement of Renagel and Renvela patents.

Beginning in January 2009, the company received notices from…

IMPAX LABS: Endo Pharma’s Patent Infringement Suit in Discovery

The patent infringement lawsuit styled Endo Pharmaceuticals Inc., et al. v. Impax Laboratories, Inc. is in discovery.

In November 2007, Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Co. filed suit against the…

IMPAX LABS: Teva Disputes Infringement of AstraZeneca’s Patents

Impax Laboratories, Inc.’s alliance agreement partner, Teva Pharmaceutical Industries, Ltd., continues to pursue invalidity or non-infringement rulings in AstraZeneca AB’s patent suit.

In litigation commenced against the Company in the U.S.…

IMPAX LABS: Jan. 2009 Trial Set for Appeal to Junked Patent Suit

A hearing for Impax Laboratories, Inc.’s appeal to the ruling dismissing its patent infringement lawsuit against Medicis Pharmaceutical Corp. is set for trial in January 2009.

In January 2008, the Company…

IMPAX LABS: Expects Injunction Ruling Over Marketing of Riluzole

The U.S. District Court for the District of Delaware is expected to enter a permanent injunction enjoining Impax Laboratories, Inc. from marketing Riluzole 50mg tablets until the expiration of Aventis…

IMPAX LABS: Boehringer & Astellas Patent Violations Suit Pending

The patent infringement lawsuit entitled Boehringer Ingelheim Pharmaceuticals, et al. v. Impax Laboratories remains pending in the U.S. District Court for the Northern District of California.

In July 2008, Boehringer Ingelheim…

IMPAX LABS: Purdue’s Tramadol Patent Breach Suit in Discovery

The patent infringement complaint filed against Impax Laboratories, Inc. by Purdue Pharma Products L.P., Napp Pharmaceutical Group LTD., Biovail Laboratories International, SRL, and Ortho-McNeil-Janssen Pharmaceuticals, Inc. is in the discovery…

IMPAX LABS: Discovery in Pfizer Patent Infringement Suit Ongoing

The patent infringement complaint filed by Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB against Impax Laboratories, Inc. is in discovery.

In March 2008, Pfizer filed the complaint…

Page 1 of 212»